CEACAM5 and non-small cell lung carcinoma: These data indicate that TP73‐AS1 and CRNDE might be valuable biomarkers for diagnosing NSCLC and that the two lncRNAs in combination with CEA or CEA/CYFRA21‐1 should be an ideal diagnostic panel for NSCLC.